rs117412802

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001846.4(COL4A2):ā€‹c.3368A>Gā€‹(p.Glu1123Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,599,498 control chromosomes in the GnomAD database, including 156 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0098 ( 13 hom., cov: 33)
Exomes š‘“: 0.012 ( 143 hom. )

Consequence

COL4A2
NM_001846.4 missense

Scores

9
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 3.57
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010744929).
BP6
Variant 13-110491254-A-G is Benign according to our data. Variant chr13-110491254-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 29629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-110491254-A-G is described in Lovd as [Likely_benign]. Variant chr13-110491254-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00979 (1490/152212) while in subpopulation NFE AF= 0.0139 (946/68006). AF 95% confidence interval is 0.0132. There are 13 homozygotes in gnomad4. There are 743 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1490 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL4A2NM_001846.4 linkuse as main transcriptc.3368A>G p.Glu1123Gly missense_variant 37/48 ENST00000360467.7 NP_001837.2 P08572A0A024RDW8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkuse as main transcriptc.3368A>G p.Glu1123Gly missense_variant 37/485 NM_001846.4 ENSP00000353654.5 P08572
COL4A2ENST00000650225.1 linkuse as main transcriptn.1023A>G non_coding_transcript_exon_variant 8/19

Frequencies

GnomAD3 genomes
AF:
0.00980
AC:
1490
AN:
152094
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00229
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00629
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00332
Gnomad FIN
AF:
0.0297
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0139
Gnomad OTH
AF:
0.00766
GnomAD3 exomes
AF:
0.00910
AC:
2047
AN:
224932
Hom.:
16
AF XY:
0.00932
AC XY:
1134
AN XY:
121716
show subpopulations
Gnomad AFR exome
AF:
0.00223
Gnomad AMR exome
AF:
0.00378
Gnomad ASJ exome
AF:
0.00293
Gnomad EAS exome
AF:
0.0000589
Gnomad SAS exome
AF:
0.00365
Gnomad FIN exome
AF:
0.0245
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
AF:
0.0121
AC:
17461
AN:
1447286
Hom.:
143
Cov.:
31
AF XY:
0.0119
AC XY:
8535
AN XY:
718390
show subpopulations
Gnomad4 AFR exome
AF:
0.00169
Gnomad4 AMR exome
AF:
0.00351
Gnomad4 ASJ exome
AF:
0.00337
Gnomad4 EAS exome
AF:
0.000204
Gnomad4 SAS exome
AF:
0.00362
Gnomad4 FIN exome
AF:
0.0272
Gnomad4 NFE exome
AF:
0.0134
Gnomad4 OTH exome
AF:
0.0102
GnomAD4 genome
AF:
0.00979
AC:
1490
AN:
152212
Hom.:
13
Cov.:
33
AF XY:
0.00998
AC XY:
743
AN XY:
74414
show subpopulations
Gnomad4 AFR
AF:
0.00229
Gnomad4 AMR
AF:
0.00628
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00332
Gnomad4 FIN
AF:
0.0297
Gnomad4 NFE
AF:
0.0139
Gnomad4 OTH
AF:
0.00758
Alfa
AF:
0.0111
Hom.:
15
Bravo
AF:
0.00725
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00223
AC:
9
ESP6500EA
AF:
0.0134
AC:
112
ExAC
AF:
0.00783
AC:
945
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024COL4A2: BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJan 09, 2017- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 24, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 28, 2018This variant is associated with the following publications: (PMID: 32172663, 22209247, 25719457, 24390199) -
Porencephaly 2 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:1
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Hemorrhage, intracerebral, susceptibility to Other:1
risk factor, no assertion criteria providedliterature onlyOMIMJan 13, 2012- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.71
D
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
0.25
D
MutationAssessor
Uncertain
2.1
M
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.47
Sift
Benign
0.081
T
Sift4G
Benign
0.098
T
Polyphen
0.96
D
Vest4
0.77
MVP
0.93
MPC
0.88
ClinPred
0.018
T
GERP RS
5.0
Varity_R
0.18
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117412802; hg19: chr13-111143601; API